Navigation Links
RSV in Medical News

PediatricRespiratory.org Announces a Two-Part, Live CME/CE Webcast Series on RSV and Pediatric Influenza

Professional Postgraduate Services® (PPS®), renowned for its award-winning healthcare websites, announces a two-part, live CME/CE webcast series on RSV and pediatric influenza, Preventing and Managing RSV Disease and Influenza Disease in Your Pediatric Practice, now available on Pediatric...

St. Jude Finds Risk Factors for Severe RSV Infection in Immunocompromised Children

Children receiving treatment for cancer who are under 2 years and those with very low levels of immune system cells called lymphocytes are at higher risk for severe respiratory syncytial virus related disease MEMPHIS, Tenn., Feb. 4 /PRNewswire-USNewswire/ -- St. Jude Children's Research Ho...

St. Jude finds risk factors for severe RSV infection in immunocompromised children

St. Jude Childrens Research Hospital investigators and collaborators have shown how to predict if a child who is infected with respiratory syncytial virus (RSV) while being treated for cancer or another catastrophic disease is at high risk for developing severe infection. The finding will help cli...

MedImmune to present RSV surveillance and cost-effectiveness data at American Academy of Pediatrics

SAN FRANCISCO, October 26, 2007 MedImmune, Inc. today announced it will present three abstracts at the American Academy of Pediatrics (AAP) 2007 National Conference & Exhibition, adding to the companys growing body of research into the prevention of respiratory syncytial virus (RSV), a leading ca...

Medimmune announces phase 2 safety data for anti-RSV antibody and national RSV surveillance results

SAN DIEGO, October 4, 2007 MedImmune, Inc. today announced results from two important studies presented at the 2007 Infectious Diseases Society of America (IDSA) 45th Annual Meeting adding to the body of knowledge about respiratory syncytial virus (RSV). RSV is a viral pathogen that produces ann...

MedImmune presents new pharmaco-economic data at AAP regarding infants at high risk for RSV

SAN FRANCISCO, October 29, 2007 MedImmune today announced results from a recent economic analysis of Synagis (palivizumab), a monoclonal antibody (MAb) that is the standard of care for prevention of severe lower respiratory tract infection due to respiratory syncytial virus (RSV) in high-risk inf...

Parental Knowledge Of RSV Infections Is Vital

Respiratory syncytial virus (RSV) is one of the primary diseases affecting the children below two years. It is prevalent during the winter seasons. RSV infections start by the end of November and the incidence increases and reaches a peak by the month of December. // Deborah Lehman, MD, associat...

Physicians To Discuss Ways To Save Premature Babies From RSV

Physicians from across the world are gathering for National Association of Neonatal Nurses Lead Media Teleconference, USA, to review that data and discuss ways of preventing occurrence of RSV to premature babies. // More than 300,000 premature infants are born prior to 36 weeks gestation each ...

MedImmune Expands Access for Eligible Premature Infants to Receive Synagis(R) at No Cost

...re information about the help that's available for rsv prevention and treatment can be found by visiting ...usually in the thigh muscle, each month during the rsv season. Children who develop an rsv infection while receiving Synagis should continue ...

First of its kind study identifies risk factors for LRTIs in Inuit children

... (RSV) the most common cause of lower respiratory tract infections. The vaccine is used only for prevention and is usually a monthly injection during rsv season. The results demonstrated that by immunizing rural Inuit infants with the vaccine, the health care system could save money up to $8,000 per...
RSV in Medical Technology

MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants

Prospective Study Seeks to Assess RSV Burden in Outpatient Setting During First Year of Life; Reinforcing Commitment to Pediatric Research GAITHERSBURG, Md., June 29 /PRNewswire/ -- MedImmune continues to advance its commitment to pediatric research with today's announcement of the first ob...

MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants

Results Showing Burden of RSV Disease Presented at Pediatric Academic Societies' Annual Meeting BALTIMORE, May 5 /PRNewswire/ -- MedImmune today announced results from a recent study it sponsored, performed by the Kaiser Permanente Division of Research in Oakland, CA, assessing risk factors f...

MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results

- Data Presented at Infectious Diseases Society of America (IDSA) 45TH Annual Meeting - SAN DIEGO, Oct. 4 /PRNewswire/ -- MedImmune, Inc. today announced results from two important studies presented at the 2007 Infectious Diseases Society of America (IDSA) 45th Annu...

MedImmune's Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study

GAITHERSBURG, Md., Aug. 23 /PRNewswire/ -- MedImmune, Inc. today announced that in a Phase 3 study, motavizumab was shown to reduce hospitalizations due to respiratory syncytial virus (RSV) by 83 percent as compared to placebo (8.3 percent in placebo arm vs. 1.4 percent in motavizumab; p<0.001...

MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV

SAN FRANCISCO, Oct. 29 /PRNewswire/ -- MedImmune today announced results from a recent economic analysis of Synagis(R) (palivizumab), a monoclonal antibody (MAb) that is the standard of care for prevention of severe lower respiratory tract infection due to respiratory syncytial virus (RSV) in ...

MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease

- Numax Achieves Primary Endpoint Among High-Risk Infants Versus Current Standard of Care and Shows Reduction of Medically Attended Outpatient RSV- Related Lower Respiratory Infections - TORONTO, May 08, 2007 /PRNewswire-FirstCall/ -- MedImmune, Inc. today announced positive results from a large p...

Novavax Announces Preclinical Data for Respiratory Syncytial Virus Vaccine Candidate

... Novavax's first vaccine candidate for the prevention of rsv ROCKVILLE, Md., Dec. 8 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) announced today that Dr. Trudy Morrison, PhD, Professor of M...

MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine

...vere respiratory syncytial virus (RSV) infections. rsv is the most common respiratory infection in infant...the National Institutes of Health, to help address rsv disease in children. The vaccine was originally de...ins, Ph.D. and Brian R. Murphy, M.D. About RSV rsv is the most important cause of viral lower respira...

Study Shows Physician Judgment is Important in Reducing Rate of RSV-Related Hospitalizations Among High-Risk Infants

...yncytial virus (RSV) disease in high-risk infants. rsv is a leading cause of viral respiratory infection .... Fifty percent of those infants received Synagis. rsv prophylaxis was requested, but not administered in... of these infants. This group was found to have an rsv hospitalization rate of 8.3 percent, which was alm...

Phase 3 Data Regarding Anti-RSV Antibody To Be Presented at Pediatric Academic Societies (PAS) Annual Meeting

...d that motavizumab reduced hospitalizations due to rsv by 83 percent as compared to placebo (8.3 percent ...SV. This study confirmed the high rates of serious rsv disease in this population. An interim analysis, r...al evidence demonstrating that motavizumab reduced rsv hospitalizations and LRIs requiring outpatient med...
RSV in Medical Products

Clearview RSV Test Kit

Description: Clearview RSV is a simple, immunochromatographic assay to aid in the diagnosis of respiratory syncytial virus (RSV) infections in children less than 6 years and adults over age 60....
Company:Inverness Point of Care

NOW RSV Test

Description: The NOW RSV Test is one of the easiest tests to run on the market today. Rapid results are available in 15 minutes with no hands-on time. Critical care instructions can be provided to parents prior to the child leaving the pediatrician's office and valuable information can be obtained prior to hosp...
Company:Inverness Point of Care

SAS RSV Test Kit

Description: The SAS RSV antigen test is a visual and rapid assay for the presumptive qualitative detection of Respitory Syncytial(RSV) antigen directly from nasopharyngeal specimens in neonatal and pediatric patients. This one-step 15 minute test has a built-in procedural control and can be stored at room temp...
Company:MarketLab

ImmunoCard STAT!® RSV PLUS

Description: Rapid Immunoassay for the detection of Respiratory Syncytial Virus....
Company:Meridian Bioscience, Inc.

PathoDx RSV Kit

Description: Immunofluorescence test for detecting RSV in direct specimens and cultures....
Company:Remel Inc.

BD Directigen RSV Test

Description: BD Directigen RSV Test fast, easy and accurate, its truly STAT. And it will help your laboratory quickly and confidently support critical antiviral therapy recommendations....
Company:BD Diagnostic Systems

Fisher Sure-Vue RSV Test Kit

Description: Rapid immunochromatographic membrane test for RSV. Accepts nasopharyngeal washes, aspirates, and swabs....
Company:ThermoFisher Scientific

ImmunoCard STAT!® RSV

Description: One step Immunochromatographic Assay for the detection of Respiratory Syncytial Virus...
Company:Meridian Bioscience, Inc.

MERIFLUOR® RSV

Description: IFA for the direct detection of Respiratory Syncytial Virus (RSV)...
Company:Meridian Bioscience, Inc.

Xpect RSV

Description: Rapid, visual assay for the presumptive qualitative detection of Respiratory Syncytial Virus (RSV) directly from nasopharyngeal specimens in neonatel and pediatric patients....
Company:Remel Inc.

More>>

RSV in Medical Dictionary

Rapid heartbeat

...t rate that is faster than normal. ... Cocaine abuse and alcohol withdrawal are other causes of rapid heartbeat . ... Rapid Heartbeat . rsv Infection. Slow Heartbeat . Sudden Infant Death Syndrome. Vomiting ... That is, they alternate rapid breathing with slow breathing. This ... ...

Immunoglobulin

...er HL, Del Mar C. Immunoglobulin treatment for respiratory syncytial virus infection. ... This review assesses immunoglobulin treatment of rsv infection ... Immunoglobulin deficiency syndromes are a group of disorders that involve ... All classes of immunoglobulin antibodies are d...
RSV in Biological News

Novel antiviral technology inhibits RSV infection in mice

A novel antiviral treatment combining nanoparticle and gene silencing technologies thwarts attacks of respiratory syncytial virus (RSV) -- a virus associated with severe bronchitis and asthma, an animal study by University of South Florida researchers found. The study was reported in the January 20...

RSV may hide in the lungs, lead to asthma, UT Southwestern researchers report

...Medical Center researchers, however, suggests that rsv may hide in the lungs even after other symptoms ab...ecurrent wheezing due to a virus such as RSV." rsv is the leading cause of viral respiratory infectio... children worldwide. Half of all babies develop an rsv infection within the first year of life and practi...

Tips from the Journals of the American Society for Microbiology

...r nearly as effective (more than 95%) as the cell culture, or gold standard, in both sensitivity and specificity. Only test results for rhinovirus and rsv came in under 95%. In addition, compared to the RSV-specific ICA, the RespiFinder showed a specificity and sensitivity of approximately 80%. The...

RNA interference therapy heals growth deficiency disorder in a live animal

...eveloping highly targeted therapies for a number of genetic diseases including macular degeneration in the eye and to block viruses such as herpes and rsv respiratory viruses. To the best of our knowledge, this is the first time it has been used to correct a dominant negative disorder in a living animal,...

Scientists find predisposition to bronchiolitis in some babies

...ator. Bronchiolitis frequently develops in infants suffering from respiratory syncytial virus (RSV) infection. Although most infants infected with rsv have only mild symptoms such as a cough and wheeze some develop potentially life-threatening bronchiolitis. Babies born prematurely are particularly s...

UQ research heralds vaccine technology breakthrough

...earch centre director Professor Robert Tindle said rsv cost millions of dollars a year in health care in ...as prevent against it. Those most at risk from rsv are children aged two and under, especially those ...s of life. The mature paediatric market for an rsv vaccine has been estimated at approximately US$800...

RNAi shows promise in gene therapy, Stanford researcher says

...the viruses that cause hepatitis and HIV in mice. With three human RNAi gene therapy trials now under way - two in macular degeneration and one in rsv pneumonia - the technique Kay pioneered may be among the first to find widespread use for treating human diseases. "We've worked on a gene therapeut...

Silver bullet: UGA researchers use laser, nanotechnology to rapidly detect viruses

...g nanotechnology, a team of University of Georgia researchers has developed a diagnostic test that can detect viruses as diverse as influenza, HIV and rsv in 60 seconds or less. In addition to saving time, the technique ?which is detailed in the November issue of the journal Nano Letters ?could save li...

Flu not the only germ threat this time of year

...that from flu. Even though flu gets all the press, rsv is a stealth bug worthy of attention too. Ann F...nit of the Department of Medicine, have found that rsv affects elderly and high-risk adults as much as th... elderly and high-risk adults die annually from an rsv infection, and that the bug is responsible for mor...

Biota makes major antiviral discovery

...ass of orally-effective, potent antivirals against rsv (respiratory syncytial virus) infection. Biota has...ical development prior to human clinical trials. rsv infection is an important medical need and already...ients: premature infants. If successful, the Biota rsv drug is expected to have significant advantages an...
RSV in Biological Technology

MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease

BOSTON, Oct. 11 /PRNewswire-USNewswire/ -- MedImmune announced today it will present four abstracts at the American Academy of Pediatrics (AAP) 2008 National Conference & Exhibition that add to the company's growing body of research into the prevention of respiratory syncytial virus (RSV), a le...

MedImmune to Present RSV Surveillance and Cost-Effectiveness Data at American Academy of Pediatrics National Conference & Exhibition

SAN FRANCISCO, Oct. 26 /PRNewswire/ -- MedImmune, Inc. today announced it will present three abstracts at the American Academy of Pediatrics (AAP) 2007 National Conference & Exhibition, adding to the company's growing body of research into the prevention of respiratory syncytial virus (RSV), a...

Aktiv-Dry Awarded Research Grant to Explore Inhalable siRNA Dry Powder Targeting RSV

BOULDER, Colo., Nov. 12 /PRNewswire/ -- Aktiv-Dry LLC has been awarded an SBIR research grant from the Center for Disease Control and Prevention (CDC) to explore the formulation of certain siRNA products as inhalable dry powders that might eventually be used to treat pulmonary disorders such a...

Novavax Announces Selection of a Respiratory Syncytial Virus Vaccine Candidate for Advanced Preclinical Studies

...announced, Novavax has been evaluating a number of rsv vaccine candidates, all of which have successfully...idate which has been shown to protect mice against rsv disease and can be produced at sufficient yields t... the vaccine protected mice against replication of rsv in the lungs. The study included groups of mice t...

Novavax Announces Appointment of John J. Trizzino as Senior Vice President, International and Government Alliances

...In addition, Mr. Trizzino's responsibilities at MedImmune and work with the rsv (Respiratory Syncytial Virus) market should be most valuable to Novavax as we continue development of our own rsv vaccine. I am excited to have him join our Company and look forward to his...

NOVAVAX Announces Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate Directed Against the Fusion (F) Protein

...ix (i.e., "core") protein decorated with the human rsv F protein. The VLPs mimic the three-dimensional structure of rsv but cannot replicate and cause disease because the...responses observed with either live or inactivated rsv immunization. The VLPs induced strong cell mediat...

NOVAVAX and the University of Massachusetts Medical School Announce Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate

...avax's first recombinant VLP for the prevention of rsv disease. The preclinical study evaluated t... of Newcastle Disease Virus decorated with a human rsv attachment glycoprotein (Ga), which is important f... mice were immunized with one of four doses of the rsv VLP vaccine candidate, inactivated RSV, live RSV, ...

Depth of MedImmune's Respiratory Disease Research Program Highlighted at Annual Meeting of the American Thoracic Society

...on: Evidence for T-Lymphocyte Independent Antibody Responses in Primary rsv Infection, publication page A190)-Sunday, May 18 from 8:15 a.m. - 4:15 ...jury (Poster Session: Role for Alveolar Macrophages in Limiting Primary rsv Immunopathology, publication page A623) - Tuesday, May 20 from 8:15 ...

Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process

... (H1,2008) Measles and rsv Phase I Phase I in children ...clinical development and funding are pending. The program for measles and rsv will be tested up to and through clinical Phase I, where it is expected tha...

MedImmune Submits Biologics License Application to FDA for Motavizumab

...help reinforce the positive role that MAbs play in rsv prevention within the current clinical body of evi...ce. It also reinforces our position as a leader in rsv prevention," said Genevieve Losonsky, M.D., vice p...ident, clinical development, infectious disease. rsv is a leading cause of viral respiratory infection ...
Other Tags
(Date:3/4/2015)... (PRWEB) March 04, 2015 Starting February ... LASIK and PRK procedures at their new location in ... Dr. Joseph King and Dr. Gabriel Chu also provide ... in Surrey is named Fraser Valley Cataract and Laser ... accredited by the College of Physicians and Surgeons of ...
(Date:3/4/2015)... Alliance Healthcare Foundation (AHF), a non-profit organization working ... in San Diego and Imperial Counties, announced today that ... Grants program with awards totaling $1 million. , ... Support Grants program. Grant recipients were chosen through a ... committee, as well as the community as a whole. ...
(Date:3/4/2015)... " Optrix by Body Glove ” ... Tech Report, which takes a look at the latest ... Scott Steinberg, a special reporter for NewsWatch and a ... viewers how they have an ultra-rugged, waterproof case with ... a major player at the Consumer Electronics Show in ...
(Date:3/4/2015)... As seen on Advanced Fertility Center ... a painful condition in which the lining of the ... leading to very unpleasant symptoms and complications that greatly ... terrible effect on women’s quality of life due to ... cause of infertility in women and carries a huge ...
(Date:3/4/2015)... 04, 2015 The New Mel Brooks ... music, will be performed by the award-winning Drama Department ... this March 6-22, 2015, on Fridays, Saturdays and Sundays. ... High School (27118 Silver Spur Road, Rolling Hills ... the program or may be purchased on-line at ...
Breaking Medicine News(10 mins):Health News:King LASIK relocates to Surrey, British Columbia 2Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 2Health News:Alliance Healthcare Foundation Awards $1 million through Mission Support Grants Program 3Health News:A Waterproof Phone Case with an Interchangeable Lens System was Featured on NewsWatch Television on January 30, 2015 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 2Health News:Advanced Fertility Center of Texas Brings Awareness to the Month of March-Endometriosis Awareness Month 3Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2
(Date:1/22/2015)... MELBOURNE, Fla. , Jan. 13, 2015  Today, ... wearable technology, launched its crowdfunding campaign on Fundable, ... accelerate the build of production capacity to meet ... Photo - http://photos.prnewswire.com/prnh/20150113/168790 ...
(Date:1/22/2015)... man-made form of insulin delivered by nasal spray may ... with mild cognitive impairment and Alzheimer,s disease dementia, according ... Forest Baptist Medical Center. The study,s subjects ... (MCI) or mild to moderate Alzheimer,s dementia (AD). Those ...
(Date:1/22/2015)... YORK , Jan. 21, 2015  Analyst Report Issued by ... Card Brands report showed that planet-wide, transactions at merchants on ... while the total number of credit, debit, and prepaid cards ... U.S. were victims of fraudulent card usage in 2012, and ...
Breaking Biology News(10 mins):FreeWavz Launches on Fundable to Drive Speed-to-Market in 2015 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
Other Contents